|transkript 3/2023 ist da!
|transkript, one of our German magazines, has been the leading industry publication for biotechnology and life sciences in German-speaking Europe since 1995. It covers current information, opinions, and background on business, research, and politics.
In this issue:
After more than 15 years of stagnation in the field of green biotechnology, it seems that the showdown in Brussels is imminent, and the final battle in the ideological conflict over plant biotechnology is approaching. The European Commission has presented its regulatory proposal for plants bred using “new genomic techniques”. Whether Europe is on the verge of adopting the most liberal regulation in the world is a matter of intense debate.
Other topics:
- Biosimilars on the rise
- Biotech saves pharma
- Attacks from the internet
- “Not all of us are vegans” – Interview with Tanja Bogumil, Lovely Day Foods GmbH
- Facelift for SPRIND
- Research: Nancy Faeser seeks to loosen data protection
- The government reinvests profits from CO2 certificates
- |transkript-Spezial on clinical trials with a focus on BIO-Europe
- LABORWELT-Spezial: Gene and cell therapy
Read the issue here: |transkript 3/2023